Grace Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Grace Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
  • Grace Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$852K, a 91% decline year-over-year.
  • Grace Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$2.67M, a 72.9% increase year-over-year.
  • Grace Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$1.83M, a 80.8% increase from 2022.
  • Grace Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$9.54M, a 1373% decline from 2021.
  • Grace Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$648K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.83M +$7.71M +80.8% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-21
2022 -$9.54M -$8.89M -1373% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-21
2021 -$648K -$648K Apr 1, 2021 Mar 31, 2022 10-K 2023-06-23
2020 $0 $0 Apr 1, 2020 Mar 31, 2021 10-K 2022-06-21
2019 $0 $0 Apr 1, 2019 Mar 31, 2020 10-K 2020-06-29
2018 $0 Apr 1, 2018 Mar 31, 2019 10-K 2020-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.